Source: CNS Drugs. Unidade: FMRP
Subjects: ESCLEROSE MÚLTIPLA (ESTUDO), CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COMINI-FROTA, Elizabeth R. et al. Evaluation of serum levels of chemokines during interferon-'beta' treatment in multiple sclerosis patients: A 1-year, observational cohort study. CNS Drugs, v. 25, n. 11, p. 913-931, 2011Tradução . . Disponível em: https://doi.org/10.2165/11595900-000000000-00000. Acesso em: 24 maio 2024.APA
Comini-Frota, E. R., Teixeira, A. L., Angelo, J. P. A., Andrade, M. V., Brum, D. G., Kaimen-Maciel, D. R., et al. (2011). Evaluation of serum levels of chemokines during interferon-'beta' treatment in multiple sclerosis patients: A 1-year, observational cohort study. CNS Drugs, 25( 11), 913-931. doi:10.2165/11595900-000000000-00000NLM
Comini-Frota ER, Teixeira AL, Angelo JPA, Andrade MV, Brum DG, Kaimen-Maciel DR, Foss NT, Donadi EA. Evaluation of serum levels of chemokines during interferon-'beta' treatment in multiple sclerosis patients: A 1-year, observational cohort study [Internet]. CNS Drugs. 2011 ; 25( 11): 913-931.[citado 2024 maio 24 ] Available from: https://doi.org/10.2165/11595900-000000000-00000Vancouver
Comini-Frota ER, Teixeira AL, Angelo JPA, Andrade MV, Brum DG, Kaimen-Maciel DR, Foss NT, Donadi EA. Evaluation of serum levels of chemokines during interferon-'beta' treatment in multiple sclerosis patients: A 1-year, observational cohort study [Internet]. CNS Drugs. 2011 ; 25( 11): 913-931.[citado 2024 maio 24 ] Available from: https://doi.org/10.2165/11595900-000000000-00000
